EUVIMEDEUVIMED entdecken
Open Access

Management and follow-up strategies for patients with head and neck paraganglioma

Susan Richter iD, Karel Pacak iD, Henricus P M Kunst, Andrzej Januszewicz, Svenja Nölting, Hanna Remde iD, Mercedes Robledo iD, Graeme Eisenhofer iD, Henri J L M Timmers, Christina Pamporaki

European Journal of Endocrinology · 2024

DOI: 10.1093/ejendo/lvae113 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Endocrinology, 2024. Verfasst von Susan Richter und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Clinical Chemistry and Laboratory Medicine, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresd…. Hauptthemen laut MEDLINE: Head and Neck Neoplasms, Paraganglioma, Succinate Dehydrogenase. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: German Research Foundation, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Head-neck paragangliomas (HNPGLs) are rare tumors with approximately half arising due to germline pathogenic variants (PVs) in succinate dehydrogenase genes (SDHx). Patients with HNPGL have heterogeneous propensity to recur and metastasize. Thus, we aim to assess prevalence and predictors of recurrent (RD) and/or metastatic disease in patients with and without SDHx-related HNPGLs. Design and methods This cross-sectional study used retrospective data of 214 patients enrolled in six referral centers. Data included sex, age, primary tumor treatment, location, and size, biochemical phenotype, germline PVs, presence of RD (locoregional or new tumor), and/or metastasis.

Results

Patients with and without SDHx-related HNPGLs showed 74% and 40% prevalence of RD, respectively. Patients without SDHx-related HNPGLs presented with recurrent tumors only in head-neck regions. The only independent predictor for RD in the entire cohort was presence of SDHx PVs. Metastatic prevalence reached 9%-13%. For patients with SDHx-related HNPGLs, large tumor size (>2.3 cm, OR:50.0, CI:2.6-977.6), young age at initial diagnosis (<42years, OR:27.3, CI:1.8-407.2), and presence of SDHB PV (OR:15.6; CI:1.5-164.8) were independent predictors of metastasis. For patients without SDHx-related HNPGLs, only carotid-body location was an independent predictor of metastasis (OR:18.9, CI:2.0-182.5).

Conclusions

Patients without SDHx-related HNPGLs require long-term follow-up due to high prevalence of RD with imaging largely restricted to head-neck regions. As carotid-body HNPGLs have the highest metastatic risk among sporadic tumors, radical treatment with frequent follow-up is suggested until population-based data are available. Importantly, patients with SDHx-related HNPGLs might benefit from early radical treatment when tumors are still small to reduce metastatic risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Head and Neck NeoplasmsParagangliomaSuccinate DehydrogenaseHumansMaleFemaleMiddle AgedAdultRetrospective StudiesCross-Sectional StudiesAgedFollow-Up StudiesNeoplasm Recurrence, LocalYoung AdultPrevalenceAdolescent

Stichwörter der Autor:innen

clinical guidancegermline testingsporadicsuccinate dehydrogenase

Substanzen

Succinate Dehydrogenase

Autor:innen und Institutionen

  • Institute for Clinical Chemistry and Laboratory Medicine, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, 01307 Dresden, Germany.
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda 20892, MD, United States.
  • Department of Otorhinolaryngology, Radboud University Medical Centre, 6525 GA Nijmegen, The Netherlands.
  • Dutch Academic Alliance Skull Base Pathology, Maastricht University Medical Center+, 6229 HX Maastricht, The Netherlands.
  • Department of Hypertension, National Institute of Cardiology, 04-628 Warsaw, Poland.
  • Medizinische Klinik and Poliklinik IV, Ludwig-Maximilians-Universität München, 80336 Munich, Germany.

ORCID-Profile: Susan Richter, Karel Pacak, Hanna Remde, Mercedes Robledo, Graeme Eisenhofer

Förderung

  • German Research Foundation
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Richter, S., Pacak, K., Kunst, H. P. M., Januszewicz, A., Nölting, S., Remde, H., Robledo, M., Eisenhofer, G., Timmers, H. J. L. M., & Pamporaki, C. (2024). Management and follow-up strategies for patients with head and neck paraganglioma. European Journal of Endocrinology. https://doi.org/10.1093/ejendo/lvae113

Vancouver

Richter S, Pacak K, Kunst HPM, Januszewicz A, Nölting S, Remde H, et al. Management and follow-up strategies for patients with head and neck paraganglioma. European Journal of Endocrinology. 2024. doi:10.1093/ejendo/lvae113

BibTeX
@article{Richter2024,
  author = {Richter, Susan and Pacak, Karel and Kunst, Henricus P M and Januszewicz, Andrzej and Nölting, Svenja and Remde, Hanna and Robledo, Mercedes and Eisenhofer, Graeme and Timmers, Henri J L M and Pamporaki, Christina},
  title = {Management and follow-up strategies for patients with head and neck paraganglioma},
  journal = {European Journal of Endocrinology},
  year = {2024},
  doi = {10.1093/ejendo/lvae113}
}
Kostenlos starten →